Hofmann, Jonathan N.

Carcinogenicity of Perfluorooctanoic Acid and Perfluorooctanesulfonic Acid

Zahm, S., Bonde, J. P., Chiu, W. A., Hoppin, J., Kanno, J., Abdallah, M., Blystone, C. R., Calkins, M. M., Dong, G.-H., Dorman, D. C., et al. (2024) · The Lancet Oncology

Per- and polyfluoroalkyl substances researchCarcinogens and Genotoxicity Assessment

Cited by 387

Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Landgren, O., Hofmann, J. N., McShane, C. M., Santo, L., Hultcrantz, M., Korde, N., Mailankody, S., Kazandjian, D., Murata, K., Thoren, K., et al. (2019) · JAMA Oncology

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research

Cited by 103

Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium

Schinasi, L. H., Brown, E. E., Camp, N. J., Wang, S. S., Hofmann, J. N., Chiu, B. C., Miligi, L., Beane Freeman, L. E., de Sanjose, S., Bernstein, L., et al. (2016) · British Journal of Haematology

Multiple Myeloma Research and TreatmentsMultiple and Secondary Primary Cancers

Cited by 57